Infection of mice with a human influenza A/H3N2 virus induces protective immunity against lethal infection with influenza A/H5N1 virus

被引:88
|
作者
Kreijtz, J. H. C. M. [1 ]
Bodewes, R. [1 ]
van den Brand, J. M. A. [1 ]
de Mutsert, G. [1 ]
Baas, C. [1 ]
van Amerongen, G. [1 ]
Fouchier, R. A. M. [1 ]
Osterhaus, A. D. M. E. [1 ]
Rimmelzwaan, G. F. [1 ]
机构
[1] Erasmus MC, Dept Virol, NL-3000 CA Rotterdam, Netherlands
关键词
Influenza virus; Heterosubtypic immunity; Cytotoxic T lymphocytes; CD8(+) T-CELLS; A VIRUS; HETEROSUBTYPIC IMMUNITY; HETEROTYPIC IMMUNITY; LYMPHOCYTES-T; M2; PROTEIN; HONG-KONG; H5N1; VACCINE; NUCLEOPROTEIN;
D O I
10.1016/j.vaccine.2009.05.079
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The transmission of highly pathogenic avian influenza (HPAI) A viruses of the H5N1 subtype from poultry to man and the high case fatality rate fuels the fear for a pandemic outbreak caused by these viruses. However, prior infections with seasonal influenza A/H1N1 and A/H3N2 viruses induce heterosubtypic immunity that could afford a certain degree of protection against infection with the HPAI A/H5N1 viruses, which are distantly related to the human influenza A viruses. To assess the protective efficacy of such heterosubtypic immunity mice were infected with human influenza virus A/Hong Kong/2/68 (H3N2) 4 weeks prior to a lethal infection with HPAI virus A/Indonesia/5/05 (H5N1). Prior infection with influenza virus A/Hong Kong/2/68 reduced clinical signs, body weight loss, mortality and virus replication in the lungs as compared to naive mice infected with HPAI virus A/Indonesia/5/05. Priming by infection with respiratory syncytial virus, a non-related virus did not have a beneficial effect on the outcome of A/H5N1 infections, indicating that adaptive immune responses were responsible for the protective effect. In mice primed by infection with influenza A/H3N2 virus cytotoxic T lymphocytes (CTL) specific for NP366-374 epitope ASNENMDAM and PA(224-232) SCLENFRAYV were observed. A small proportion of these CTL was cross-reactive with the peptide variant derived from the influenza A/H5N1 virus (ASNENMEVM and SSLENFRAYV respectively) and upon challenge infection with the influenza A/H5N1 virus cross-reactive CTL were selectively expanded. These CTL, in addition to those directed to conserved epitopes, shared by the influenza A/H3N2 and A/H5N1 viruses, most likely contributed to accelerated clearance of the influenza A/H5N1 virus infection. Although also other arms of the adaptive immune response may contribute to heterosubtypic immunity, the induction of virus-specific CTL may be an attractive target for development of broad protective vaccines. Furthermore the existence of pre-existing heterosubtypic immunity may dampen the impact a future influenza pandemic may have. (C) 2009 Elsevier Ltd. All rights reserved.
引用
收藏
页码:4983 / 4989
页数:7
相关论文
共 50 条
  • [1] Vaccination against Human Influenza A/H3N2 Virus Prevents the Induction of Heterosubtypic Immunity against Lethal Infection with Avian Influenza A/H5N1 Virus
    Bodewes, Rogier
    Kreijtz, Joost H. C. M.
    Baas, Chantal
    Geelhoed-Mieras, Martina M.
    de Mutsert, Gerrie
    van Amerongen, Geert
    van den Brand, Judith M. A.
    Fouchier, Ron A. M.
    Osterhaus, Albert D. M. E.
    Rimmelzwaan, Guus F.
    PLOS ONE, 2009, 4 (05):
  • [2] Vaccination against Seasonal Influenza A/H3N2 Virus Reduces the Induction of Heterosubtypic Immunity against Influenza A/H5N1 Virus Infection in Ferrets
    Bodewes, R.
    Kreijtz, J. H. C. M.
    Geelhoed-Mieras, M. M.
    van Amerongen, G.
    Verburgh, R. J.
    van Trierum, S. E.
    Kuiken, T.
    Fouchier, R. A. M.
    Osterhaus, A. D. M. E.
    Rimmelzwaan, G. F.
    JOURNAL OF VIROLOGY, 2011, 85 (06) : 2695 - 2702
  • [3] Oseltamivir protects ferrets against lethal H5n1 influenza virus infection
    Govorkova, EA
    Ilyushina, NA
    Smith, J
    Webster, RG
    ANTIVIRAL RESEARCH, 2006, 70 (01) : A29 - A29
  • [4] Recombinant modified vaccinia virus Ankara-based vaccine induces protective immunity in mice against infection with influenza virus H5N1
    Kreijtz, Joost H. C. M.
    Suezer, Yasemin
    van Amerongen, Geert
    de Mutsert, Gerrie
    Schnierle, Barbara S.
    Wood, John M.
    Kuiken, Thijs
    Fouchier, Ron A. M.
    Loewer, Johannes
    Osterhaus, Albert D. M. E.
    Sutter, Gerd
    Rimmelzwaan, Guus F.
    JOURNAL OF INFECTIOUS DISEASES, 2007, 195 (11): : 1598 - 1606
  • [5] DNA vaccine encoding hemagglutinin provides protective immunity against H5N1 influenza virus infection in mice
    Kodihalli, S
    Goto, H
    Kobasa, DL
    Krauss, S
    Kawaoka, Y
    Webster, RG
    JOURNAL OF VIROLOGY, 1999, 73 (03) : 2094 - 2098
  • [6] Infection with H9N2 influenza viruses confers immunity against lethal H5N1 infection
    O'Neill, E
    Seo, SH
    Woodland, DL
    Shortridge, KF
    Webster, RG
    OPTIONS FOR THE CONTROL OF INFLUENZA IV, 2001, 1219 : 775 - 781
  • [7] Influenza type A (H5N1) virus infection
    Engin, Aynur
    MIKROBIYOLOJI BULTENI, 2007, 41 (03): : 485 - 494
  • [8] Human infection with highly pathogenic H5N1 influenza virus
    Gambotto, Andrea
    Barratt-Boyes, Simon M.
    de Jong, Menno D.
    Neumann, Gabriele
    Kawaoka, Yoshihiro
    LANCET, 2008, 371 (9622): : 1464 - 1475
  • [9] Human avian influenza A (H5N1) virus infection in China
    CuiLin Xu
    LiBo Dong
    Li Xin
    Yu Lan
    YongKun Chen
    LiMei Yang
    YueLong Shu
    Science in China Series C: Life Sciences, 2009, 52 : 407 - 411
  • [10] Human avian influenza A (H5N1) virus infection in China
    XU CuiLin
    ScienceinChina(SeriesC:LifeSciences), 2009, 52 (05) : 407 - 411